Stock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target

Stock Track

2025/02/19

ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.

Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.

While the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1133311511"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133311511\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133311511?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-19 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133311511","market":"us","top_or_hot":-1,"title":"Stock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target","media":"Stock Track","content":"<p>ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.</p>\n\n<p>Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.</p>\n\n<p>While the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-02-19 22:33</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.</p>\n\n<p>Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.</p>\n\n<p>While the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ORIC","symbol_name":"Oric Pharmaceuticals Inc.","start_time":0,"source_url":"","article_id":"1133311511","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133311511","pubTimestamp":1739975619,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ORIC Pharmaceuticals Inc.  stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.While the specific reasons behind Jefferies' price target increase","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ORIC":"Oric Pharmaceuticals Inc."},"translate_title":"Jefferies上调目标价，ORIC Pharmaceuticals盘前飙升9.17%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORIC":1},"content_text":"ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.\nJefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.\nWhile the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}